Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research.

Tytuł:
Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research.
Autorzy:
Shringarpure K; Department of Community Medicine, Medical College Baroda, Baroda, Gujarat, India .
Gurumurthy M; Research Division, Vital Strategies, Singapore.; TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India.
Sagili KD; TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India.
Taylor M; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Garner P; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Tonsing J; TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India.; The Global Fund to Fight AIDS Tuberculosis and Malaria, Grand-Saconnex, Geneva, Switzerland.
Rao R; National Tuberculosis Elimination Programme (NTEP), Central TB Division, India Ministry of Health and Family Welfare, New Delhi, India.
Sachdeva KS; TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India.; National Tuberculosis Elimination Programme (NTEP), Central TB Division, India Ministry of Health and Family Welfare, New Delhi, India.
Źródło:
BMJ open [BMJ Open] 2023 May 04; Vol. 13 (5), pp. e063926. Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
MeSH Terms:
Patient Compliance*
Tuberculosis*/drug therapy
Humans ; Health Personnel ; Qualitative Research ; Reproducibility of Results
References:
Multidiscip Respir Med. 2018 Mar 22;13:10. (PMID: 29599974)
BMC Med Res Methodol. 2012 Nov 27;12:181. (PMID: 23185978)
BMC Public Health. 2014 Jan 17;14:46. (PMID: 24438351)
PLoS One. 2020 Jan 15;15(1):e0227293. (PMID: 31940375)
BMC Health Serv Res. 2016 Jul 19;16:283. (PMID: 27430557)
PLoS Med. 2007 Feb;4(2):e37. (PMID: 17298164)
Trop Med Int Health. 2013 Sep;18(9):1128-1133. (PMID: 23837468)
Int J Tuberc Lung Dis. 1999 Apr;3(4):300-9. (PMID: 10206500)
Int J Tuberc Lung Dis. 2006 Sep;10(9):1008-12. (PMID: 16964792)
Qual Health Res. 2019 Jul;29(8):1109-1119. (PMID: 30499375)
PLoS One. 2019 Jan 10;14(1):e0210408. (PMID: 30629648)
Health Policy Plan. 2005 Nov;20(6):354-65. (PMID: 16183735)
PLoS One. 2015 Aug 24;10(8):e0135802. (PMID: 26301748)
Int J Tuberc Lung Dis. 2001 Oct;5(10):887-93. (PMID: 11605880)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
PLoS Med. 2007 Jul 24;4(7):e238. (PMID: 17676945)
Glob Public Health. 2014;9(10):1239-51. (PMID: 25223868)
BMC Health Serv Res. 2013 Jul 31;13:290. (PMID: 23899353)
Am Rev Respir Dis. 1991 Oct;144(4):745-9. (PMID: 1928942)
PLoS Med. 2018 Jul 3;15(7):e1002595. (PMID: 29969463)
Public Health Action. 2018 Dec 21;8(4):187-193. (PMID: 30775279)
BMC Public Health. 2009 Jun 17;9:190. (PMID: 19534811)
Bull World Health Organ. 2008 Mar;86(3):B-D. (PMID: 18368191)
Trop Med Int Health. 2002 Aug;7(8):693-700. (PMID: 12167096)
Lancet. 2014 Sep 20;384(9948):1095. (PMID: 25241715)
BMJ Open. 2018 Jan 21;8(1):e019287. (PMID: 29358443)
Cochrane Database Syst Rev. 2015 Sep 03;(9):CD007952. (PMID: 26333525)
J Family Med Prim Care. 2022 Jun;11(6):3006-3012. (PMID: 36119340)
Lancet. 2000 Apr 15;355(9212):1345-50. (PMID: 10776760)
Int J Tuberc Lung Dis. 2008 Jul;12(7):837-47. (PMID: 18544214)
J Epidemiol Glob Health. 2017 Dec;7(4):219-225. (PMID: 29110861)
BMJ Open. 2019 Jul 9;9(7):e025707. (PMID: 31289061)
Int J Prev Med. 2010 Fall;1(4):223-32. (PMID: 21566777)
Ethiop Med J. 1994 Apr;32(2):97-106. (PMID: 8033883)
Indian J Public Health. 2022 Jan-Mar;66(1):38-44. (PMID: 35381712)
Int J Tuberc Lung Dis. 2002 Sep;6(9):780-8. (PMID: 12234133)
PLoS One. 2015 Nov 12;10(11):e0142384. (PMID: 26562787)
Int J Tuberc Lung Dis. 2004 Dec;8(12):1492-8. (PMID: 15636497)
Anthropol Med. 2007 Aug;14(2):139-51. (PMID: 27268389)
Int J Tuberc Lung Dis. 1998 Nov;2(11):891-7. (PMID: 9848609)
Indian J Tuberc. 2007 Apr;54(2):66-70. (PMID: 17575677)
J Trop Pediatr. 2017 Aug 1;63(4):274-285. (PMID: 28082666)
Int J Tuberc Lung Dis. 2004 Oct;8(10):1260-5. (PMID: 15527160)
Cochrane Database Syst Rev. 2022 Feb 17;2:CD013638. (PMID: 35174482)
PLoS Med. 2019 Dec 10;16(12):e1002884. (PMID: 31821323)
Cochrane Database Syst Rev. 2015 May 29;(5):CD003343. (PMID: 26022367)
Tanaffos. 2013;12(4):28-34. (PMID: 25191481)
PLoS One. 2016 Mar 09;11(3):e0150849. (PMID: 26959366)
Trop Med Int Health. 2003 Jul;8(7):625-33. (PMID: 12828545)
Kekkaku. 2008 Dec;83(12):765-72. (PMID: 19172821)
Bull World Health Organ. 2007 May;85(5):404-6. (PMID: 17639229)
Glob Health Action. 2019;12(1):1568826. (PMID: 30712507)
Health Promot Int. 2015 Jun;30(2):262-9. (PMID: 23793302)
PLoS One. 2016 Mar 21;11(3):e0151321. (PMID: 26998830)
Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275)
Southeast Asian J Trop Med Public Health. 2008 Nov;39(6):1076-82. (PMID: 19062698)
Int J Tuberc Lung Dis. 2014 Dec;18(12):1479-84. (PMID: 25517815)
PLoS One. 2010 Apr 06;5(4):e10043. (PMID: 20386611)
PLoS One. 2014 Feb 03;9(2):e88290. (PMID: 24498440)
Am J Public Health. 2011 Apr;101(4):654-62. (PMID: 21330583)
Int J Tuberc Lung Dis. 2002 Jul;6(7):573-9. (PMID: 12102295)
Trop Med Int Health. 2004 Jul;9(7):833-41. (PMID: 15228495)
Am J Speech Lang Pathol. 2015 Nov;24(4):S838-53. (PMID: 26140581)
Int J Infect Dis. 2009 May;13(3):362-8. (PMID: 19008141)
J Health Popul Nutr. 2010 Apr;28(2):114-23. (PMID: 20411673)
Cochrane Database Syst Rev. 2014 Nov 18;(11):CD006594. (PMID: 25403701)
Clin Infect Dis. 2013 Jul;57(1):21-31. (PMID: 23487389)
BMC Public Health. 2011 Mar 25;11:188. (PMID: 21439062)
Contributed Indexing:
Keywords: health policy; public health; tuberculosis
Entry Date(s):
Date Created: 20230504 Date Completed: 20230508 Latest Revision: 20230512
Update Code:
20240105
PubMed Central ID:
PMC10163483
DOI:
10.1136/bmjopen-2022-063926
PMID:
37142319
Czasopismo naukowe
Objectives: How well patients adhere to their tuberculosis (TB) treatment influences their recovery and development of drug resistance, but influences on adherence are multiple and often competing. We synthesised qualitative studies from our setting in the Indian subcontinent to understand the dimensions and dynamics involved to help inform service provision.
Design: Qualitative synthesis comprising inductive coding, thematic analysis and forming a conceptual framework.
Data Sources: Medline (OVID), Embase (OVID), CINAHL (EBSCOHost), PsycINFO (EBSCOHost), Web of Science Core Collection, Cochrane Library and Epistemonikos were databases searched on 26 March 2020 for studies published since 1 January 2000.
Eligibility Criteria for Selecting Studies: We included reports in English from the Indian subcontinent that used qualitative or mixed-methodology designs and reported findings around adherence to TB treatment. Full texts meeting eligibility were sampled based on 'thickness' (the richness of the qualitative data reported).
Data Extraction and Synthesis: Two reviewers used standardised methods to screen abstracts and code. Included studies were assessed for reliability and quality using a standard tool. Qualitative synthesis was performed by inductive coding, thematic analysis and developing conceptual framework.
Results: Of 1729 abstracts screened from initial search, 59 were shortlisted for full-text review. Twenty-four studies that qualified as 'thick' were included in the synthesis. Studies were set in India (12), Pakistan (6), Nepal (3), Bangladesh (1) or in two or more of these countries (2). Of the 24 studies, all but one included people who were taking TB treatment (1 study included only healthcare providers), and 17 included healthcare workers, community members or both.We identified three themes: (1) personal influences on the people with TB include interconnections between their social role in the family unit, their own priorities in day-to-day living and their experience to date with the disease; (2) adherence is profoundly influenced by how individual healthcare providers interact with patients on treatment and address their needs; (3) adherence is influenced across communities by structural, social, economic and cultural factors related to treatment.
Conclusion: Staff in TB programmes require an understanding of the various competing influences on individuals undergoing treatment. Programmes need to have more flexible and people-centred approaches to service provision in order to achieve adherence, and thus improve treatment outcomes.
Prospero Registration Number: CRD42020171409.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies